RESUMO
BACKGROUND AND OBJECTIVES: The relative safety and efficacy of monthly extended-release buprenorphine (XR-BUP) has not been fully evaluated in pregnant persons. METHODS: Case report of two pregnant individuals receiving XR-BUP while pregnant. RESULTS: Both patients had positive experiences and healthy infants. DISCUSSION AND CONCLUSIONS: Sparse data regarding the use of XR-BUP in pregnant patients limits shared decision-making. Additional evidence will support the growing population of pregnant patients exposed to XR-BUP. SCIENTIFIC SIGNIFICANCE: Positive patient experiences using XR-BUP during pregnancy have been previously unreported. This report will contribute to discussions of risks and benefits for future patients using XR-BUP during pregnancy.
